Abstract
随着世界卫生组织新治疗指南的发布及越来越多口服抗结核药物临床数据的产生，从不良反应、患者的依从性、治疗方式的改变等方面考虑，注射剂将逐渐被口服药物取代，这是历史进步、科学发展的必然趋势。但考虑到当前新指南中部分A、B组药物在我国的可及性、氟喹诺酮类药物在我国的耐药率较高、大部分A、B组药品价格昂贵且尚未全面纳入医保且建议的"理想"全口服方案费用较高，患者难以承受，故认为注射剂在我国耐药结核病治疗中仍有一定的作用，在一段时间内将会出现含注射剂方案和口服药物方案并行的情况。.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
